Inhibikase is a company innovating small-molecule kinase inhibitor therapeutics targeting CNS disease, including diseases of the brain. MORE
April 09, 2019 Inhibikase Therapeutics Announces Appointment of Elizabeth O’Farrell to its Board of Directors
March 19, 2019 Inhibikase Therapeutics Expands its Scientific Advisory Board with the Appointment of Leading Experts in Parkinson’s Disease